These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 9134225

  • 1. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R.
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [Abstract] [Full Text] [Related]

  • 2. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 3. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP.
    Cancer Res; 1995 Jul 01; 55(13):2822-30. PubMed ID: 7796409
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain.
    Morimoto S, Imanaka S, Koh E, Shiraishi T, Nabata T, Kitano S, Miyashita Y, Nishii Y, Ogihara T.
    Biochem Int; 1989 Nov 01; 19(5):1143-9. PubMed ID: 2561444
    [Abstract] [Full Text] [Related]

  • 5. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
    Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5624-8. PubMed ID: 6594194
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3.
    Gniadecki R, Serup J.
    Biochem Pharmacol; 1995 Mar 01; 49(5):621-4. PubMed ID: 7887976
    [Abstract] [Full Text] [Related]

  • 7. 1,25-Dihydroxy-vitamin-D3 enhances antiproliferative effect and transcription of TGF-beta1 on human keratinocytes in culture.
    Kim HJ, Abdelkader N, Katz M, McLane JA.
    J Cell Physiol; 1992 Jun 01; 151(3):579-87. PubMed ID: 1295905
    [Abstract] [Full Text] [Related]

  • 8. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML, Daneels G, Geysen J, Binderup L, Kragballe K.
    Pharmacol Toxicol; 1997 Jan 01; 80(1):49-56. PubMed ID: 9148283
    [Abstract] [Full Text] [Related]

  • 9. Biphasic effect of 1,25-dihydroxyvitamin D3 on primary mouse epidermal keratinocyte proliferation.
    Bollag WB, Ducote J, Harmon CS.
    J Cell Physiol; 1995 May 01; 163(2):248-56. PubMed ID: 7706369
    [Abstract] [Full Text] [Related]

  • 10. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression.
    Dai X, Sayama K, Shirakata Y, Tokumaru S, Yang L, Tohyama M, Hirakawa S, Hanakawa Y, Hashimoto K.
    J Dermatol Sci; 2008 Apr 01; 50(1):53-60. PubMed ID: 18077140
    [Abstract] [Full Text] [Related]

  • 11. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes.
    Gibson DF, Bikle DD, Harris J.
    J Cell Physiol; 1998 Jan 01; 174(1):1-8. PubMed ID: 9397150
    [Abstract] [Full Text] [Related]

  • 12. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD, Posner GH, Greising DM, White MC, Sylvia VL, Dean DD, Schwartz Z.
    J Cell Biochem; 1997 Sep 15; 66(4):457-70. PubMed ID: 9282324
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol.
    Rizk-Rabin M, Zineb R, Zhor B, Michèle G, Jana P.
    J Cell Physiol; 1994 Apr 15; 159(1):131-41. PubMed ID: 8138581
    [Abstract] [Full Text] [Related]

  • 14. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes.
    Ratnam AV, Bikle DD, Cho JK.
    J Cell Physiol; 1999 Feb 15; 178(2):188-96. PubMed ID: 10048583
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ, Reddy GS, Koeffler HP.
    J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197
    [Abstract] [Full Text] [Related]

  • 16. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 17. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.
    Chem Biol; 1999 May 01; 6(5):265-75. PubMed ID: 10322128
    [Abstract] [Full Text] [Related]

  • 18. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
    Itin PH, Pittelkow MR, Kumar R.
    Endocrinology; 1994 Nov 01; 135(5):1793-8. PubMed ID: 7956903
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R.
    Anticancer Drugs; 1995 Feb 01; 6(1):101-8. PubMed ID: 7756673
    [Abstract] [Full Text] [Related]

  • 20. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
    Park K, Bae H, Heydemann A, Roberts AB, Dotto GP, Sporn MB, Kim SJ.
    Cancer Res; 1994 Dec 01; 54(23):6087-9. PubMed ID: 7954451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.